Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 8,027 shares at $7.01 ($56K) on 2017-02-28, disclosed to the SEC on 2017-03-01.
Open-market sale of $56k STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.97 | 4,000 | $28K | 49.7% |
| 2 | $7.01 | 4,027 | $28K | 50.3% |
| Total | $6.99 avg | 8,027 | $56K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |